Effects of treatment with somatostatin analogues on the occurrence of apoptosis in somatotropinomas

Neuroendocrinology Letters

Volumn 24, Issue 5, 2003, Pages 334-338

  Wasko, Ryszard ^a   Jankowska, Anna ^a   Kotwicka, Malgorzata ^a   Liebert, Wlodzimierz ^a   Sowinski, Jerzy ^a   Warchol, Jerzy Bozydar ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Apoptosis; Lanreotide; Pituitary; Somatostatine analogue; Somatotropinomas

Indexed keywords

ANGIOPEPTIN; DNA FRAGMENT; SOMATOSTATIN DERIVATIVE;

ADULT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CELL DAMAGE; CELL STRUCTURE; CELL VACUOLE; CHROMATIN CONDENSATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOCRINE CELL; FEMALE; HORMONE RELEASE; HUMAN; HUMAN CELL; HYPOPHYSIS ADENOMA; MALE; MICROSCOPY; MITOCHONDRION; NUCLEOSOME; SURGICAL APPROACH; TRANSSPHENOIDAL HYPOPHYSECTOMY; TREATMENT OUTCOME;

EID: 0242552431     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Aoki A, de Gaisan ED, Pasolli HA, Torres AI. Disposal of cell debris from surplus lactotrophs of pituitary gland. Exp Clin Endocrinol Diabetes 1996; 104:256-62.
2. Kaynard AH, Periman LM, Simard J, Melner MH. Ovarian 3 beta-hydroxysteroid dehydrogenase and sulfated glycoprotein-2 gene expression are differentially regulated by the induction of ovulation, pseudopregnancy and luteolisis in the immature rat. Endocrinology 1992; 130:2192-200.
3. Tilly JL. Apoptosis and the ovary: a fashionable trend or food for thought. Fertil Steril 1996; 67:226-8.
4. Arends MJ, Wyllie AH. Mechanisms and roles of apoptosis in pathology. Int Rev Exp Pathol 1991; 32:223-54.
5. Hsueh AJ, Eisenhauer K, Chun SY, Hsu SY, Billig H. Gonadal cell apoptosis. Recent Prog Horm Res 1996; 51:433-56.
6. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol; 1995; 146:3-15.
7. Pan H, Yin C, van Dyke T. Apoptosis and cancer mechanisms. Cancer Surv 1997; 29:305-27.
8. Thompson CB. Apoptosis in the Pathogenesis and Treatment of Disease. Science 1995; 267:1456-61.
9. Armstrong RC, Aja TJ, Hoang KD, Gaur S, Bai X, Alnemri ES et al. Activation of the CED3/ICE - related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J Neurosci 1997; 17:553-62.
10. Chien KR, Abrams J, Serroni A, Martin JT, Farber JL. Accelerated phospholipids degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury. J Biol Chem 1978; 253:4809-17.
11. Martin SJ, Cotter TG. Disruption of microtubules induced an endogenous suicide pathway in human leukemia HL-60 cells. Cell Tissue Kinet 1990; 23:545-59.
12. Gong J, Traganos F, Darzynkiewicz Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 1994; 218:314-9.
13. Amato G, Mazziotti G, Rotondi M, Iorio S, Doga M, Sorvillo F et al. Long-term effect of Lanreotide SR and Octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. Clin Endocrinol (Oxf) 2002; 56:65-71.
14. Wasko R, Ruchala M, Sawicka J, Liebert W, Kotwicka M, Sowinski J. Short-term pre-surgical treatment with somatostatin analogues, octreotide and lanreotide in acromegaly. J Clin Endocrinol Invest 2000; 23:12-8.
15. Stewart PM. Current therapy for acromegaly. Trends Endocrinol Metab 2000; 11:128-32.
16. Morange I, Boisvilliers F, Chanson P. Slow release lancreotide treatment in acromegalic patients previously normalised by ocreotide. J Clin Endocrinol Metab 1994; 79:145-51.
17. Stevenaert A, Harris AG, Kovacs K. Presurgical octreotide treatment in acromegaly. Metabolism 1992; 41:51-8.
18. Heron I, Thomas F, Dero M, Gancel A, Ruiz JM, Schatz B et al. Pharmacokinetics and efficacy of a long-acting formulation of the new somatostatine analog BIM 23014 in patients with acromegaly. J Clin Endocrinol Metab 1993;76:721-7.
19. Shimon I, Melmed S. Management of pituitary tumours. Ann Intern Med 1998; 15:472-83.
20. Sassolas G. Medical Therapy with somatostatine analogues for acromegaly. Eur J Endocrinol 1995;133:675-7.
21. Viollet C, Prevost G, Maubert E, Faivre Bauman A, Gardette R, Kordon Cet al. Molecular pharmacology of somatostatine receptors. Fundam Clin Pharmacol 1995; 9:107-13.
22. Mucha G, Winczyk K, Pawlikowski M. Somatostatin analogue octreotide and melatonin inhibit bromodeoxyuridine incorporation into cell nuclei and enhance apoptosis in the transplantable murine colon 38 cancer. Anticancer Res 1998; 18:3615-20.
23. Szegedi Z, Takacs J, Szende B, Vadasz Z, Horvath A, Gulyas E et al. A specifically radiolabeled somatostatine analog with strong antitumor activity induces apoptosis and accumulates in the cytosol and the nucleus of HT29 human colon carcinoma cells. Endocrine 1999; 10:25-34.
24. Yin D, Kondo S, Takeuchi J, Morimura T. Induction of apoptosis in murine ACTH-secreting pituitary adenoma cells by bromocriptine. FEBS Lett 1994; 339:73-5.
25. Kontogeorgos G, Sambaziotis D, Piaditis G, Karameris A. Apoptosis in human pituitary adenomas: a morphologic and in situ end labeling study. Mod Pathol 1997; 10:921-6.
26. Saitoh Y, Arita N, Ohnishi T, Ekramullah S, Takemura K, Hayakawa T. Absence of apoptosis in somatotropinomas treated with octreotide. Acta Neurochir (Wien)1997; 139:851-6.